Section Arrow
AZTA.NASDAQ
- Azenta
Quotes are at least 15-min delayed:2025/11/15 01:13 EST
Regular Hours
Last
 29.75
-0.13 (-0.44%)
Day High 
30.04 
Prev. Close
29.88 
1-M High
33.1 
Volume 
405.55K 
Bid
11.96
Ask
31
Day Low
29.17 
Open
29.3 
1-M Low
28.95 
Market Cap 
1.37B 
Currency USD 
P/E -- 
%Yield 0.34 
10-SMA 30.21 
20-SMA 30.79 
50-SMA 30.61 
52-W High 55.635 
52-W Low 23.91 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-2.52/1.12
Enterprise Value
1.43B
Balance Sheet
Book Value Per Share
36.51
Cash Flow
Cash Flow Yield
0.06
Income Statement
Total Revenue
656.32M
Operating Revenue Per Share
13.75
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
MLSSMilestone Scientific0.33-0.0497-13.09%-- 
AVTRAvantor11.38-0.32-2.74%11.55PE
BAXBaxter International18.47-0.23-1.23%140.32PE
HOLXHologic74.15-0.11-0.15%30.81PE
XRAYDENTSPLY SIRONA10.52-0.43-3.93%-- 
Quotes are at least 15-min delayed:2025/11/15 01:13 EST
Industry overview quotes are at least 15 minutes delayed
Business Description
Azenta Inc is a provider of life sciences solutions, enabling impactful breakthroughs and therapies to market faster. It provides a full suite of reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally. The company has three reportable segments that are Sample Management Solutions, Multiomics, and B Medical Systems. It generates a substantial part of its revenue from its Sample Management Solutions segment.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.